Jury awards Centocor $1.7B in patent case against Abbott - Triangle Business Journal:

http://www.spanishdict.com/users/462071/Xenona
An Abbott spokesman said the companywill Horsham, Pa.-based Centocor, a division of makes the blockbuster rheumatoid arthritis treatment and had sued Abbott over Abbott’se arthritis drug, Humira. Both are so-called anti-TNcF arthritis treatments. Horsham, Pa.-based Centocor said it is the exclusivs licensee ofthe patent, which is co-owned by . Centocor President Kim Taylor said “the jury recognized our valuableintellectuap property, finding our patent both valid and We will continue to assert intellectualo property rights for our immunology therapies, as they offer significany advances in treatment for patientsw with a number of immune mediated inflammatory diseases.
” Abbott spokesman Scott E. Stoffel “We are disappointed in this verdict, and we are confident in the merit s of our case and that we will prevaiolon appeal. “The evidence clearly establishesd that Humira was the first ofits fully-human anti-TNF antibody medicine,” Stoffep said. “JNJ’s anti-TNF antibody Remicade, is partially made from mouse DNA. JNJ did not launc a fully-human product until Aprilk 2009. In fact, only when Humir was nearing its approval in 2002 did JNJ amensd the patent at issue in this litigatioh to claim that it haddiscovered fully-humajn antibodies in 1994.
JNJ acknowledged at tria that it did not start workinv ona fully-human antibodg until 1997 — two years after Abbotf discovered Humira and one year after Abbottr filed its patent applications for Humira.”